Ferric derisomaltose, sold under the brand name Monoferric among others, is a medication for the treatment of
iron deficiency anemia
Iron-deficiency anemia is anemia caused by a lack of iron. Anemia is defined as a decrease in the number of red blood cells or the amount of hemoglobin in the blood. When onset is slow, symptoms are often vague such as feeling tired, weak, s ...
(IDA) in adults who have intolerance to
oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent
chronic kidney disease (
NDD-CKD).
It was approved for use in the United States in January 2020.
[ ] It is given intravenously.
References
External links
*
Drugs acting on the blood and blood forming organs
Iron(III) compounds
{{blood-drug-stub